We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Neurology

Journal Scan / Research · August 01, 2022

Long-Term Effectiveness of IVIg Maintenance Therapy in Patients With GAD Antibody–Positive Stiff-Person Syndrome

Neurology(R) Neuroimmunology & Neuroinflammation

 

Additional Info

Neurology(R) Neuroimmunology & Neuroinflammation
Long-term Effectiveness of IVIg Maintenance Therapy in 36 Patients With GAD Antibody-Positive Stiff-Person Syndrome
Neurol Neuroimmunol Neuroinflamm 2022 Sep 01;[EPub Ahead of Print], J Yi, MC Dalakas

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading